The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -73.89%.However, over the last six months, we can see a stronger performance of -47.26%. Over the last 30 days, the price of MRVI has fallen by 15.07%. And in the last five days, it has fallen by -11.90%.
At present, Maravai LifeSciences Holdings Inc (MRVI) has a stock price of $2.4. In the previous session, the stock saw a rise, peaking at $10.0 after an opening price of $2.4. The day’s lowest price was $2.0, and it closed at $2.51.
Maravai LifeSciences Holdings Inc experienced a rather shaky stock market performance.
52-week price history of MRVI Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Maravai LifeSciences Holdings Inc’s current trading price is -76.02% away from its 52-week high, while its distance from the 52-week low is 44.44%. The stock’s price range during this period has varied between$1.66 and $10.03. The Maravai LifeSciences Holdings Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.81 million for the day, a figure considerably lower than their average daily volume of 1.82 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Maravai LifeSciences Holdings Inc (MRVI) has experienced a quarterly rise of 39.83% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 612.46M and boasts a workforce of 570 employees.
Maravai LifeSciences Holdings Inc: Analysts’ Ratings Unveiled
As of right now, 5 analysts are rating Maravai LifeSciences Holdings Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 6 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.31, with a change in price of -1.61. Similarly, Maravai LifeSciences Holdings Inc recorded 2,640,627 in trading volume during the last 100 days, posting a change of -40.02%.
MRVI’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MRVI stands at 1.09. Similarly, the long-term debt-to-equity ratio is also 1.07.
MRVI Stock Stochastic Average
Maravai LifeSciences Holdings Inc’s raw stochastic average for the past 50 days is presently 46.43%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 42.93%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 51.23% and 57.70%, respectively.
